Clevudine
Clevudine (L-FMAU), a nucleoside analog of the unnatural L-configuration, has potent anti-HBV activity with long half-life, low toxicity. Clevudine is a non-competitive inhibitor that is not incorporated into the viral DNA but rather binds to the polymerase. Clevudine is active against cowpox virus respiratory infection in mice[1][2][3].
Product Specifications
CAS Number
163252-36-6
Product Name Alternative
L-FMAU
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
DNA/RNA Synthesis; HBV; Orthopoxvirus
Type
Oligonucleotides
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Clevudine.html
Purity
99.93
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : ≥ 50 mg/mL
Smiles
O[C@@H]1[C@@H](F)[C@@H](N2C(NC(C(C)=C2)=O)=O)O[C@H]1CO
Molecular Formula
C10H13FN2O5
Molecular Weight
260.22
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Oligonucleotides
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
C9ORF74 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
DAP5 (Death Associated Protein 5, EIF4g2, Eukaryotic Elongation Factor 4 gamma 2)
DAP5 (Death Associated Protein 5, EIF4g2, Eukaryotic Elongation Factor 4 gamma 2)
Recombinant Human TGFB1/TGF-beta 1 Protein (His Tag)